ISTH Congress Abstracts

Official abstracts site for the ISTH Congress

MENU 
  • Home
  • Congress Archive
    • ISTH 2020 Congress
  • Resources
  • Search

ISTH 2020 Congress

Platelet Disorders and von Willebrand Disease » Acquired Thrombocytopenias

Theme Navigation

  • ISTH 2020 Congress
    • Platelet Disorders and von Willebrand Disease
      • Acquired Thrombocytopenias

Abstract Number: PB1365

A Long Term Survival Chronic DIC with ITP Treated with Low Dose Steroid

Y. Seki, O. Nagano

Abstract Number: PB1369

A Subpopulation of ITP Patients Resembling Glanzmann Thrombasthenia Phenotype Revealed by Flow Cytometry Analysis of Platelet Intracellular Signalling

A. Martyanov1,2,3, D.S. Morozova4, S.S. Uzueva3, M.A. Sorokina3, D.V. Fedorova3, P.A. Zharkov3, M.A. Panteleev2,3,5, A.N. Sveshnikova2,3,5

Abstract Number: PB1335

Achieving Clinically Relevant Platelet Count Response Thresholds with Avatrombopag (AVA) in Immune Thrombocytopenia (ITP)

I. Altomare1, M. Vredenburg2, W. Tian2, K. Aggarwal2

Abstract Number: PB1377

Antimicrobial Prophylaxis in Patients with Immune Thrombocytopenia Treated with Rituximab: A Retrospective Multicenter Analysis

S. Raso1, M. Napolitano2, G. Arrigo1, F. Reale1, P. Silimbiani3, A. Lucchesi4, A. Maggio5, G. Calvaruso5, U. Consoli6, M.F. Mansueto1, S. Siragusa2

Abstract Number: PB1327

Antithyroid Treatment Improves Thrombocytopenia in a Young Patient with Graves´ Disease: A Case Report

V.V. Palmieri, G. Lassandro, A. Amoruso, V. Palladino, C. Pastore, P. Giordano

Abstract Number: PB1328

Apoptotic Markers May Help in Predicting the Disease Course of Pediatric Immune Thrombocytopenic Patients

S. Levy Mendelovich1, S. Aviner2, N. Sharon3, H. Miskin4, J. Yacobovich5, G. Kenet1, H. Hauschner6, N. Rosenberg1

Abstract Number: PB1366

Artificial Neural Network for Prediction of Hemorrhagic Severity in Patients with Immune Thrombocytopenia Purpura

L.P. de Carvalho1, M.P. Colella2, J.M. Annichino-Bizzacchi3, T.D. Martins4

Abstract Number: PB1331

Atorvastatin Restores the Imbalance of CD4+ T cells in Immune Thrombocytopenia via Ras/MEK/ERK and mTOR/PI3K/AKT Pathways

P. Xu1, M. Xu2, M. Hou2

Abstract Number: PB1315

Can we Predict the Clinical Course of Children with ITP by MPV? A Preliminary Study

Y. Lee1, H. Yoon1, S. Cho2

Abstract Number: PB1334

Can we Predict the Outcome of Splenectomy for Primary Immune Thrombocytopenia? Conclusion Based on Systematic Review and Meta-Analysis

M. Mitrovic1,2, D. Antic1,2, N. Milic3, M. Virijevic1,2, Z. Pravdic1, N. Sabljic1, N. Pantic1, N. Suvajdzic Vukovic1,2

Abstract Number: PB1346

CD4+ T Cell Expression of IL-10 Compared to IL-17 is Lower in Patients with Immune Thrombocytopenia (ITP) Who Do Not Respond Clinically to High Dose Corticosteroid

M. Stimpson1, P. Lait1, L. Schewitz-Bowers1, E. Williams1, R. Lee1,2, C. Bradbury2,3

Abstract Number: PB1374

Characteristics and Outcome of Patients with Thrombocytopenia Secondary to Acute Cytomegalovirus Infection: Case Series and Literature Review

T. Shragai1, E. Lebel2, D. Deshet3, D. Varon1,2, I. Avivi1,4, I. Kirgner1, N. Sarid1

Abstract Number: PB1319

Characteristics of Patients with Cyclic Thrombocytopenia: An Observational Cohort Study

O. Steinbrecher1, L. Eischer1, H. Sinkovec2, M. Mitrovic3, S. Eichinger1, P.A. Kyrle1

Abstract Number: PB1340

Clinical and Laboratory Factors Affecting Chronicity in Children Diagnosed with Immune Thrombocytopenia

Y. Ay1, H. Sarbay2

Abstract Number: PB1347

Clinical Practise of SMOG System for Assessing Severity of Hemorrhagic Manifestations of Immume Thrombocytopenia (ITP) in Children

D. Sigunova, L. Zhukova, K. Papayan, A. Morozova

Abstract Number: PB1364

Comparison of Various Diagnostic Methods in Assessing Platelet Count in Patients with Immunotrombocytopenia

M. Witkowski1, M. Witkowska2, M. Tybura-Sawicka3, A. Majchrzak1, J. Treliński3, K. Chojnowski3, T. Robak4, P. Smolewski2

Abstract Number: PB1378

Corticosteroid Reduction or Discontinuation after Initiation of Avatrombopag Treatment in Patients with Chronic Immune Thrombocytopenia (ITP)

M. Recht1,2, A. Dixon3, K. Aggarwal3, M. Vredenburg3

Abstract Number: PB1330

Desmopressin for Procedures or Radiological Interventions (DRIVE): Participant Characteristics in a Placebo-Controlled Double-Blind, Randomised Feasibility Trial of Desmopressin in Thrombocytopenic Critically Ill Patients Prior to Procedures

M. Desborough1, E. Laing2, A. Griffiths3, A. Mora2, R. Hodge2, S. Martin2, A. Shah4, P. Hutton5, T. Parke6, M. Wise7, M. Morgan7, S. McKechnie5, S. Stanworth4,8, DRIVE Trial Investigators

Abstract Number: PB1336

Efficacy and Safety of Romiplostim in Children with Chronic and Persistent Immune Thrombocytopenic Purpura

M. Bordbar, M. Karimi

Abstract Number: PB1322

Elevated BAFF Promote B Cell Survival and Autoantibody Production through Upregulating Let-7b in Immune thrombocytopenia

Y. He, B. Zuo, C. Ruan

  • 1
  • 2
  • 3
  • 4
  • Next Page »

« View all themes from the ISTH 2020 Congress

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2021 John Wiley & Sons, Inc. All Rights Reserved.
Wiley
This site uses cookies: Find out more.